期刊
TARGETED ONCOLOGY
卷 5, 期 3, 页码 217-227出版社
SPRINGER
DOI: 10.1007/s11523-010-0151-8
关键词
Glioma cancer stem cells; STAT3; Glioblastoma multiforme; Immunotherapy
类别
资金
- Anthony Bullock III Foundation
- Dr. Marnie Rose Foundation
- Mitchell Foundation
- University of Texas M. D. Anderson Cancer Center
- National Institutes of Health [CA120813]
Glioblastoma multiforme (GBM) is a lethal cancer that responds poorly to radiotherapy and chemotherapy. Glioma cancer stem cells (gCSCs) have been shown to recapitulate the characteristic features of GBM and to mediate chemotherapy and radiation resistance. Immunotherapeutic targeting of this cell population holds therapeutic promise but must be considered in the context of the immunosuppressive properties mediated by the gCSC. Recent findings have indicated that this goal will be challenging because the gCSC can suppress both the innate and adaptive immune systems by a variety of gCSC-secreted products and cell-membrane interactions. In this review article, we will attempt to reconcile the disparate research findings regarding the potential of immune targeting of the gCSC and propose several novel solutions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据